Dr. Valeria Silva Merea, MD

Dr. Silva Merea practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Silva Merea's NPI, 1790051431, was assigned on March 27, 2012. Dr. Silva Merea graduated from Columbia University Vagelos College of Physicians and Surgeons in 2012. Dr. Silva Merea holds New York license 293429.

Dr. Silva Merea's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Silva Merea's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silva Merea practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Silva Merea's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Silva Merea is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Silva Merea's licenses on file in 3 states: New York, New Jersey and Ohio.

Dmand AI lists acute sinusitis, ear infection, hearing loss and impairment, larynx and vocal cord disease, tinnitus and upper respiratory infection (URI) among the conditions Dr. Silva Merea treats.

CMS data shows 812 Medicare services from Dr. Silva Merea across 11 procedure codes in 2024, for 271 Medicare patients. Medicare paid $66,468 for them. Every service was in an office.

CMS counts 271 Medicare patients who saw Dr. Silva Merea in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Silva Merea's median patient age at 72, with 47% women.

In 2024, Dr. Silva Merea wrote 160 Medicare Part D claims for 82 patients. 97% of them were for generic drugs. CMS names the drug for 101 of them, across 5 drugs with 11 or more claims each, at $1,946 in total drug cost. In 2023, CMS named 99 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Silva Merea for performance year 2024, reported as part of a group. Dr. Silva Merea accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Silva Merea as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Silva Merea, published from 2014 to 2019. 2018 was the busiest year, with 2. The most frequent topics are Voice Quality. Dr. Silva Merea has published most often in Laryngoscope. Dr. Silva Merea's most frequent co-authors are Michael S. Benninger, MD, Paul Bryson, MD and Eli Grunstein, MD.

CMS Open Payments shows 2 general payments to Dr. Silva Merea from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Olympus America Inc. paid the most, $223.

Dr. Silva Merea graduated from Columbia University Vagelos College of Physicians and Surgeons in 2012.

Dr. Silva Merea is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.